Citations

Clear

216 citation(s) found for "Ortega, V E".

Arthroscopic Parachute Technique for Split‐type Greater Tuberosity Fractures
Garcia, Ausberto Velasquez , Abdo, Glen , Martini, Liborio Ingala , Velasquez Garcia, Ausberto , Ingala Martini, Liborio

Mayo Clinic

Arthroscopy Techniques | February 13, 2023 | Volume: 12 | Issue: 3 | Pages: No page available

10.1016/j.eats.2022.11.014 | PMID 37013012 Get It

Abstract Over the past years, several arthroscopic fixation procedures have been adopted for fractures of the greater tuberosity. Although they offer advantages over open approaches, especially for avulsion‐type fixation, split‐type fractures are usually treated with open reduction and internal fixation. However, suture constructs can result in a more reliable fixation system for multifragment or osteoporotic split‐type fractures. Currently, the use of arthroscopic techniques in these more complex fractures is questionable due to inherent limitations of anatomic reduction and stability concerns. The authors report a technically simple and reproducible arthroscopic procedure based on anatomic, morphologic, and biomechanical concepts, which offers advantages over traditional open approaches or double‐row arthroscopic techniques in the treatment of most split‐type greater tuberosity fractures. Technique Video video See video under supplementary data.
Low-Dose ACTH Stimulation Test in Obesity: A Randomized Dose Assessment
Mancillas‐Adame, Leonardo , Sánchez‐García, Adriana , Rodríguez‐Gutiérrez, René , Gonzalez‐Velazquez, Camilo , Lavalle‐González, Fernando J. , Zuñiga-Hernández, Jorge A , Rios-Ortega, Adriana Gabriela , González‐González, José Gerardo , Mancillas-Adame, Leonardo G , Lavalle-Gonzalez, Fernando Javier , González-González, José Gerardo , Zuñiga-Hernandez, Jorge Alberto , González-Velázquez, Camilo , Sánchez-García, Adriana

Mayo Clinic

International Journal of Endocrinology | November 19, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-5

10.1155/2022/7860272 | PMID 36457351 Get It

Background. The short cosyntropin test is widely used for adrenal insufficiency screening and diagnosis. Lower cosyntropin doses may have greater sensitivity vs. the standard dose in detecting adrenal dysfunction. Obesity and overweight are increasing, impacting the clinical presentation of some diseases. Currently more than 50% of the subjects diagnosed with autoimmune adrenal insufficiency have a BMI greater than 25, and hence individuals living with overweight and obesity are more frequently requiring evaluation of the adrenal cortical function. Fixed-dose cosyntropin stimulation may not be appropriate for individuals with obesity. Objective. The primary objective was to compare cortisol response to a weight-adapted cosyntropin dose vs. a fixed low dose (1 µg) and a more physiologically fixed dose (10 µg). Methods. Twenty individuals with obesity and 20 age-matched healthy controls underwent in a randomized sequence at least one-week apart, to the The short cosyntropin test with three different doses, 0.2 µg/kg of body weight, 1 or 10 µg fixed dose stimuli. The assessment and data analysis were blinded to the individual and the investigator. Results. Cortisol response was reduced in the group with obesity with the 1 µg fixed dose stimuli at 30 minutes (median, IQR) 649.6 µg, 567.3–738.4 µg for the control group vs. 568.6 µg, 528.4–623.13 µg, p = 0.04 ; there was a lower cortisol peak at 60′ in all the three evaluated doses, with a dose-dependent trend. A weight-adapted cosyntropin dose of 0.2 µg in obesity produces a similar response to the one observed in individuals without obesity. The 1 µg ACTH test falls short on stimulating the cortisol adrenal response in individuals with obesity.
Prolonged, physiologically relevant nicotine concentrations in the airways of smokers
Esther, Charles R. , O’Neal, Wanda K. , Alexis, Neil E. , Koch, Abigail L. , Cooper, Christopher B. , Raffield, Laura M. , Bowler, Russel P., Comellas, Alejandro P. , Peters, Stephen P. , Hastie, Annette T. , Ronish, Bonnie , Ortega, Victor E. , Wells, J. Michael , Halper‐Stromberg, Eitan , Rennard, Stephen I. , Boucher, Richard C. , SPIROMICS, on behalf of, Hastie, Annette T , Curtis, Jeffrey L , Ronish, Bonnie , Boucher, Richard C , Raffield, Laura M , O'Neal, Wanda K , Comellas, Alejandro P , Wells, J Michael , Barjaktarević, Igor , Curtis, Jeffrey L. , SPIROMICS, on behalf of

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | November 7, 2022 | Volume: 324 | Issue: 1 | Pages: L32-L37

10.1152/ajplung.00038.2022 | PMID 36342131 Get It

Nicotine from cigarette smoke is a biologically active molecule that has pleiotropic effects in the airway, which could play a role in smoking-induced lung disease. However, whether nicotine and its metabolites reach sustained, physiologically relevant concentrations on airway surfaces of smokers is not well defined. To address these issues, concentrations of nicotine, cotinine, and hydroxycotinine were measured by mass spectrometry (MS) in supernatants of induced sputum obtained from participants in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS), an ongoing observational study that included never smokers, former smokers, and current smokers with and without chronic obstructive pulmonary disease (COPD). A total of 980 sputum supernatants were analyzed from 77 healthy never smokers, 494 former smokers (233 with COPD), and 396 active smokers (151 with COPD). Sputum nicotine, cotinine, and hydroxycotinine concentrations corresponded to self-reported smoking status and were strongly correlated to urine measures. A cutoff of ∼8–10 ng/mL of sputum cotinine distinguished never smokers from active smokers. Accounting for sample dilution during processing, active smokers had airway nicotine concentrations in the 70–850 ng/mL (∼0.5–5 µM) range, and concentrations remained elevated even in current smokers who had not smoked within 24 h. This study demonstrates that airway nicotine and its metabolites are readily measured in sputum supernatants and can serve as biological markers of smoke exposure. In current smokers, nicotine is present at physiologically relevant concentrations for prolonged periods, supporting a contribution to cigarette-induced airway disease.
Novel Privacy Considerations for Large Scale Proteomics
Yu, Bing , Gorbet, Betty A., Lange, Leslie A. , Pratte, Katherine , Coors, Marilyn E., Ortega, Victor E. , Gerzsten, Robert E., Ngo, Debby , O’Neal, Wanda K. , Meyers, Deborah A. , Bleecker, Eugene R., Banaei‐Kashani, Farnoush , Guo, Claire, O'Neal, Wanda K , Hill, Andrew , LITKOWSKI, ELIZABETH M. , Manichaikul, Ani , Kechris, Katerina , DeCamp, Matthew W. , Rich, Stephen S. , Rotter, Jerome I. , Clish, Clary B. , Curtis, Jeffrey L. , Hu, Xiaowei , Hobbs, Brian D. , Cho, Michael H. , Bowler, Russell P.

Mayo Clinic

No container title available | November 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2160242/v1 Get It

Abstract Privacy protection is a core principle of genomic but not proteomic research. We identified independent single nucleotide polymorphism (SNP) quantitative trait loci (pQTL) from COPDGene and Jackson Heart Study (JHS), calculated continuous protein level genotype probabilities, and then applied a naïve Bayesian approach to match proteomes to genomes for 2,812 independent subjects from COPDGene, JHS, SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) and Multi-Ethnic Study of Atherosclerosis (MESA). We were able to correctly match 90%-95% of proteomes to their correct genome and for 95%-99% we could match the proteome to the 1% most likely genome. The accuracy of matching in subjects with African ancestry was lower (~ 60%) unless training included diverse subjects. With larger profiling (SomaScan 5K) in the Atherosclerosis Risk Communities (ARIC) correct identification was > 99% even in mixed ancestry populations. When serial proteomes are available, the matching algorithm can be used to identify and correct mislabeled samples. This work also demonstrates the importance of including diverse populations in omics research and that large proteomic datasets (> 1,000 proteins) can be accurately linked to a specific genome through pQTL knowledge and should not be considered unidentifiable.
The Trillat Procedure for Anterior Glenohumeral Instability
Garcia, Ausberto Velasquez , Chaney, Grace K. , Martini, Liborio Ingala , Valenti, Philippe , Velasquez Garcia, Ausberto , Ingala Martini, Liborio

Mayo Clinic

JBJS Reviews | August 5, 2022 | Volume: 10 | Issue: 8 | Pages: No page available

10.2106/jbjs.rvw.22.00049 | PMID 35922397 Get It

» Anterior glenohumeral instability (AGI) is a challenging condition that requires close attention to osseous and soft-tissue abnormalities. The morphometric variance of the periarticular scapular anatomy may be involved in the pathogenesis of recurrent traumatic anterior instability. » The Trillat procedure repositions the coracoid medially and downward by a partial wedge osteotomy, mimicking the sling effect of the Latarjet procedure by moving the conjoint tendon closer to the joint line in throwing position. The Trillat procedure decreases the coracohumeral distance without affecting the integrity of the subscapularis muscle and tendon. » Joint preservation methods, such as the Trillat procedure, may be explored in older patients to treat AGI with simultaneous irreparable rotator cuff tears (RCTs) with a static centered head and a functional subscapularis. » Shoulder hyperlaxity and instability can be challenging to treat with isolated soft-tissue procedures. In cases without glenoid bone loss, free bone block techniques are ineffective because of the subsequent potential graft resorption, apprehension, or recurrence. The Trillat surgery, in conjunction with an anteroinferior capsuloplasty, seems to be helpful in preventing recurrent instability and in reducing shoulder apprehension. » Recently, several variations of the original technique have been described. In the future, anatomical, biomechanical, and clinical studies need to be conducted to further evaluate the morphometric characterization of the procedure, enhance the technical features, improve indications, and avoid coracoid impingement and other potential complications with the Trillat procedure.
Multi‐ancestry genome‐wide association study of asthma exacerbations
Herrera‐Luis, Esther , Ortega, Victor E. , Ampleford, Elizabeth J., Granell, Raquel , Roos, Emmely W. de , Terzikhan, Natalie, Vergara, Ernesto Elorduy , Hernandez‐Pacheco, Natalia , Pérez-García, Javier , Martín-González, Elena , Lorenzo-Díaz, Fabián , Group, U‐BIOPRED Study, Jorgensen, Andrea , Forno, Erick , Lethem, Ryan, Espuela‐Ortiz, Antonio , Eng, Celeste , Pérez, José María Hernández , Hawkins, Greg, Marsico, Annalisa , Bahmer, Thomas , Hansen, Gesine , Kopp, Matthias , Rios, Raimon, Cruz, María Jesús , González‐Barcala, Francisco Javier , Olaguibel, José María , Canino, Glorisa , Cloutier, Michelle M. , Rodríguez‐Santana, José, Korta‐Murua, Javier , Potočnik, Uroš , Kabesch, Michael , Mukhopadhyay, Somnath , Pirmohamed, Munir , Hawcutt, Daniel B. , Palmer, Colin N.A. , Mutius, Erika von , Celedón, Juan C. , Chew, Fook Tim , Bleecker, Eugene R. , Meyers, Deborah A. , Granell, Raquel , Hernandez-Pacheco, Natalia , Perez-Garcia, Javier , Lorenzo-Diaz, Fabian , Hashimoto, Simone , Yan, Qi , Forno, Erick , Vijverberg, Susanne J , Espuela-Ortiz, Antonio , Gorenjak, Mario , Hernández-Pérez, José M , Poza-Guedes, Paloma , Corcuera, Paula , Olaguibel, José María , Plaza, Vicente , Quirce, Santiago , Cloutier, Michelle , Del Pozo, Victoria , Figueiredo, Camila , Pirmohamed, Munir , Hawcutt, Daniel B , Melén, Erik , Palmer, Colin N A , Turner, Steve , Maitland-van der Zee, Anke H , von Mutius, Erika , Celedón, Juan C , Brusselle, Guy , Chew, Fook Tim , Burchard, Esteban G. , Pino-Yanes, Maria , Sio, Yang Yie , Brinkman, Paul , Group, U‐BIOPRED Study, González‐Pérez, Ruperto , Sardón‐Prado, Olaia , Rabe, Klaus Friedrich , Villar, Jesús

Mayo Clinic

Pediatric Allergy and Immunology | June 8, 2022 | Volume: 33 | Issue: 6 | Pages: No page available

10.1111/pai.13802 | PMID 35754128 Get It

Abstract Background Asthma exacerbations are a serious public health concern due to high healthcare resource utilization, work/school productivity loss, impact on quality of life, and risk of mortality. The genetic basis of asthma exacerbations has been studied in several populations, but no prior study has performed a multi‐ancestry meta‐analysis of genome‐wide association studies (meta‐GWAS) for this trait. We aimed to identify common genetic loci associated with asthma exacerbations across diverse populations and to assess their functional role in regulating DNA methylation and gene expression. Methods A meta‐GWAS of asthma exacerbations in 4989 Europeans, 2181 Hispanics/Latinos, 1250 Singaporean Chinese, and 972 African Americans analyzed 9.6 million genetic variants. Suggestively associated variants ( p ≤ 5 × 10 −5 ) were assessed for replication in 36,477 European and 1078 non‐European asthma patients. Functional effects on DNA methylation were assessed in 595 Hispanic/Latino and African American asthma patients and in publicly available databases. The effect on gene expression was evaluated in silico. Results One hundred and twenty‐six independent variants were suggestively associated with asthma exacerbations in the discovery phase. Two variants independently replicated: rs12091010 located at vascular cell adhesion molecule‐1/exostosin like glycosyltransferase‐2 ( VCAM1 / EXTL2 ) (discovery: odds ratio (OR T allele ) = 0.82, p = 9.05 × 10 −6 and replication: OR T allele = 0.89, p = 5.35 × 10 −3 ) and rs943126 from pantothenate kinase 1 ( PANK1 ) (discovery: OR C allele = 0.85, p = 3.10 × 10 −5 and replication: OR C allele = 0.89, p = 1.30 × 10 −2 ). Both variants regulate gene expression of genes where they locate and DNA methylation levels of nearby genes in whole blood. Conclusions This multi‐ancestry study revealed novel suggestive regulatory loci for asthma exacerbations located in genomic regions participating in inflammation and host defense.
Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity
Baugh, Aaron , Buhr, Russell G. , Quibrera, P. Miguel, Kaufman, Joel D. , Koch, Abigail L. , Mkorombindo, Takudzwa , Namen, Andrew M. , Ortega, Victor E. , Paine, Robert , Peters, Stephen P. , Schotland, Helena , Zeidler, Michelle , Hansel, Nadia N. , Woodruff, Prescott G. , Kaufman, Joel D , Ortega, Victor, Baugh, Aaron D , Buhr, Russell G , Barjaktarević, Igor , Barr, R. Graham , Bowler, Russell P. , Han, MeiLan King , Krishnan, Jerry A , Labaki, Wassim W. , Martínez, Fernando J. , Sundar, Krishna M. , Thakur, Neeta

Mayo Clinic

Sleep | June 6, 2022 | Volume: 45 | Issue: 8 | Pages: No page available

10.1093/sleep/zsac107 | PMID 35665826 Get It

Abstract Study Objectives Sleep is an important dimension in the care of chronic obstructive pulmonary disease (COPD), but its relevance to exacerbations is unclear. We wanted to assess whether sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) is associated with an increased risk of COPD exacerbations and does this differ by socio-environmental exposures. Methods We included 1647 current and former smokers with spirometrically confirmed COPD from the SPIROMICS cohort. We assessed incidence rate ratios for exacerbation using zero-inflated negative binomial regression adjusting for demographics, medical comorbidities, and multiple metrics of disease severity, including respiratory medications, airflow obstruction, and symptom burden. Our final model adjusted for socio-environmental exposures using the Area Deprivation Index, a composite measure of contemporary neighborhood quality, and Adversity–Opportunity Index, a composite measure of individual-level historic and current socioeconomic indicators. We used a pre-determined threshold of 20% missingness to undertake multiple imputation by chained equations. As sensitivity analyses, we repeated models in those with complete data and after controlling for prior exacerbations. As an exploratory analysis, we considered an interaction between socio-environmental condition and sleep quality. Results After adjustment for all co-variates, increasing PSQI scores (range 0–21) were associated with a 5% increased risk for exacerbation per point (p = .001) in the imputed dataset. Sensitivity analyses using complete cases and after controlling for prior exacerbation history were similar. Exploratory analysis suggested less effect among those who lived in poor-quality neighborhoods (p-for-interaction = .035). Conclusions Poor sleep quality may contribute to future exacerbations among patients with COPD. This represents one target for improving disease control. Clinical Trial Registration Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). ClinicalTrials.gov Identifier# NCT01969344. Registry URL: https://clinicaltrials.gov/ct2/show/.
DNA Sequencing Analysis of Cystic Fibrosis Transmembrane Regulator Gene Identifies Cystic Fibrosis-Associated Variants in the Severe Asthma Research Program
Izquierdo, Manuel, Marion, Chad R. , Moore, Wendy C. , Raraigh, Karen S. , Cutting, G., Ampleford, Elizabeth J., Hawkins, Gregory A., Castro, M., Denlinger, Loren C. , Erzurum, S.C., Fahy, J.V., Israel, Elliot , Jarjour, Nizar N. , Mauger, David, Woodruff, P., Bleecker, Eugene R. , Meyers, Deborah A. , Ortega, Victor E. , Castro, M. , Fahy, J.V., Levy, Bruce David , Wenzel, Sally E.

Mayo Clinic

B60. ASTHMA AND ALLERGIC RESPONSES: CELLS, TISSUES, AND ANIMAL MODELS | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A3244-A3244

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3244 Get It

Genetic Regulators of Sputum Mucin Concentration Revealed by GWAS and Their Associations with Chronic Bronchitis and Acute Exacerbations of COPD
Radicioni, Giorgia , Garudadri, S., Curtis, J.L., Krishnan, J.A., Wan, E.S., Silverman, Edwin K. , Hastie, Annette T. , Ortega, Victor E. , Christenson, S., Li, Yingying , Cho, M.H., Kelada, Samir N. P. , Buren, Eric C. Van , O’Neal, Wanda K. , Dang, Hong , Kasela, Silva , Curtis, J.L., Han, MeiLan King , Lappalainen, Tuuli , Li, Y., Cho, M.H. , Kesımer, Mehmet

Mayo Clinic

C66. COPD: GENETICS, GENOMICS, AND EPIGENETICS | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4666-A4666

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4666 Get It